☰

William H. Yong, MD - Publications

Affiliations: 
Pathology and Laboratory Medicine University of California, Los Angeles, Los Angeles, CA 
Website:
http://faculty.pathology.ucla.edu/institution/personnel?personnel_id=45925
Tree Info Grants Similar researchers PubMed Report error

92 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Magaki S, Haeri M, Szymanski LJ, Chen Z, Diaz R, Williams CK, Chang JW, Ao Y, Newell KL, Khanlou N, Yong WH, Fallah A, Salamon N, Daniel T, Cotter J, et al. Hyaline protoplasmic astrocytopathy in epilepsy. Neuropathology : Official Journal of the Japanese Society of Neuropathology. PMID 37198977 DOI: 10.1111/neup.12909  0.549
2022 Zhang D, Yong W, Movassaghi M, Rodriguez FJ, Yang I, McKeever P, Qian J, Li JY, Mao Q, Newell KL, Green RM, Welsh CT, Heaney AP. Whole Exome Sequencing Identifies PHF14 Mutations in Neurocytoma and Predicts Responsivity to the PDGFR Inhibitor Sunitinib. Biomedicines. 10. PMID 36359362 DOI: 10.3390/biomedicines10112842  0.607
2020 Wu X, Geng F, Cheng X, Guo Q, Zhong Y, Cloughesy TF, Yong WH, Chakravarti A, Guo D. Lipid Droplets Maintain Energy Homeostasis and Glioblastoma Growth via Autophagic Release of Stored Fatty Acids. Iscience. 23: 101569. PMID 33083736 DOI: 10.1016/J.Isci.2020.101569  0.311
2020 Patel KS, Yao J, Raymond C, Yong W, Everson R, Liau LM, Nathanson D, Kornblum H, Wang C, Oughourlian T, Lai A, Nghiemphu PL, Pope WB, Cloughesy TF, Ellingson BM. Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma. Scientific Reports. 10: 14819. PMID 32908231 DOI: 10.1038/S41598-020-71799-W  0.346
2020 Voth BL, Pelargos PE, Barnette NE, Bhatt NS, Chen CHJ, Lagman C, Chung LK, Nguyen T, Sheppard JP, Romiyo P, Mareninov S, Kickhoefer VA, Yong WH, Rome LH, Yang I. Intratumor injection of CCL21-coupled vault nanoparticles is associated with reduction in tumor volume in an in vivo model of glioma. Journal of Neuro-Oncology. PMID 32274629 DOI: 10.1007/S11060-020-03479-8  0.381
2020 Patel KS, Kejriwal S, Sun MM, Thammachantha S, Duong C, Chan A, Cherian N, Romiyo P, Gordon LK, Yong W, Wadehra M, Yang I. Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma. Journal of Neuro-Oncology. PMID 31981014 DOI: 10.1007/S11060-020-03401-2  0.356
2020 Zhang D, Damoiseaux R, Bergsneider M, Wang MB, Yong WH, Kelly KA, Heaney AP. SAT-311 Role of SREBP in Regulation of Corticotroph Tumor ACTH Secretion and Cell Proliferation Journal of the Endocrine Society. 4. DOI: 10.1210/Jendso/Bvaa046.1628  0.333
2020 Molaie D, Lai A, Ellingson BM, Nguyen T, Bahng HH, Filka E, Green S, Pope WB, Leng M, Yong WH, Green RM, Polikoff J, Spier L, Iwamoto FM, Lassman AB, et al. Phase II trial of bevacizumab and temozolomide for treatment of elderly patients with newly diagnosed glioblastoma. Journal of Clinical Oncology. 38: 2540-2540. DOI: 10.1200/Jco.2020.38.15_Suppl.2540  0.328
2020 Antonios JP, Everson RG, Mochizuki A, Khattab S, Soto H, Romiyo P, Sun MZ, Moughon D, Billingslea-Yoon E, Odesa S, Li G, Kawaguchi E, Salazar A, Yong W, Schlossman J, et al. Abstract PR13: Adjuvant TLR-3 administration enhances proinflammatory immune responses and is associated with extended survival in glioblastoma patients treated with dendritic cell vaccination Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm19-Pr13  0.344
2019 Maletkovic J, Dabbagh A, Zhang D, Zahid A, Bergsneider M, Wang MB, Linetsky M, Salamon N, Yong WH, Vinters HV, Heaney AP. Residual Tumor Confers a 10-Fold Increased Risk of Regrowth in Clinically Nonfunctioning Pituitary Tumors. Journal of the Endocrine Society. 3: 1931-1941. PMID 31598573 DOI: 10.1210/Js.2019-00163  0.357
2019 Bi J, Ichu TA, Zanca C, Yang H, Zhang W, Gu Y, Chowdhry S, Reed A, Ikegami S, Turner KM, Zhang W, Villa GR, Wu S, Quehenberger O, Yong WH, et al. Oncogene Amplification in Growth Factor Signaling Pathways Renders Cancers Dependent on Membrane Lipid Remodeling. Cell Metabolism. PMID 31303424 DOI: 10.1016/J.Cmet.2019.06.014  0.308
2019 McKinney A, Lindberg OR, Engler JR, Chen KY, Kumar A, Gong H, Lu KV, Simonds EF, Cloughesy TF, Liau LM, Prados M, Bollen AW, Berger MS, Shieh JTC, James CD, ... ... Yong WH, et al. Mechanisms of resistance to EGFR inhibition reveal metabolic vulnerabilities in human GBM. Molecular Cancer Therapeutics. PMID 31270152 DOI: 10.1158/1535-7163.Mct-18-1330  0.372
2019 Liu F, Cox CD, Chowdhury R, Dovek L, Nguyen H, Li T, Li S, Ozer B, Chou A, Nguyen N, Wei B, Antonios J, Soto H, Kornblum H, Liau L, ... ... Yong W, et al. SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation. Journal of Neuro-Oncology. PMID 30838489 DOI: 10.1007/S11060-019-03126-X  0.332
2019 Cloughesy TF, Mochizuki AY, Orpilla JR, Hugo W, Lee AH, Davidson TB, Wang AC, Ellingson BM, Rytlewski JA, Sanders CM, Kawaguchi ES, Du L, Li G, Yong WH, Gaffey SC, et al. Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nature Medicine. PMID 30742122 DOI: 10.1038/S41591-018-0337-7  0.36
2019 Zhang D, Kim SSR, Kelly DF, Asa SL, Movassaghi M, Mareninov S, Yong WH, Cloughesy TF, Rodriguez FJ, McKeever P, Qian J, Li JY, Mao Q, Newell KL, Green RM, et al. Somatostatin Receptor Ligand Therapy-A Novel Therapy for Neurocytoma. The Journal of Clinical Endocrinology and Metabolism. PMID 30722009 DOI: 10.1210/Jc.2018-02419  0.611
2019 Zhang D, Way JS, Zhang X, Sergey M, Bergsneider M, Wang MB, Yong WH, Heaney AP. Effect of Everolimus in Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas. The Journal of Clinical Endocrinology and Metabolism. PMID 30624667 DOI: 10.1210/Jc.2018-02461  0.325
2019 Magaki S, Hojat SA, Wei B, So A, Yong WH. An Introduction to the Performance of Immunohistochemistry. Methods in Molecular Biology (Clifton, N.J.). 1897: 289-298. PMID 30539453 DOI: 10.1007/978-1-4939-8935-5_25  0.336
2019 Zhang D, Bergsneider M, Wang MB, Yong WH, Heaney A. MON-466 Transcriptome Dynamics of in vitro Human Pituitary Tumor Primary Culture Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Mon-466  0.306
2019 Yao J, Nathanson D, Yong WH, Salamon N, Lai A, Leia Nghiemphu P, Prins R, Pope W, Czernin J, Everson R, Liau L, Cloughesy T, Ellingson B. NIMG-60. IDH MUTANT GLIOMAS WITH 1p/19q CO-DELETION ARE LESS ACIDIC THAN NON-CO-DELETED GLIOMAS AS MEASURED WITH PH-WEIGHTED AMINE CEST-MRI AND AMINO ACID PET Neuro-Oncology. 21: vi174-vi175. DOI: 10.1093/Neuonc/Noz175.729  0.311
2018 Kepe V, Scafoglio C, Liu J, Yong WH, Bergsneider M, Huang SC, Barrio JR, Wright EM. Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas. Journal of Neuro-Oncology. PMID 29525972 DOI: 10.1007/S11060-018-2823-7  0.306
2018 Goode B, Mondal G, Hyun M, Ruiz DG, Lin YH, Van Ziffle J, Joseph NM, Onodera C, Talevich E, Grenert JP, Hewedi IH, Snuderl M, Brat DJ, Kleinschmidt-DeMasters BK, Rodriguez FJ, ... ... Yong WH, et al. A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle. Nature Communications. 9: 810. PMID 29476136 DOI: 10.1038/S41467-018-02826-8  0.551
2018 Ligon K, Lupo J, Molinaro A, Block S, Charbonneau S, Geduldig J, Stemmer-Rachamimov A, DeAngelis L, Yong W, Schultz N, Young R, Huang R, Chang S, Arrillaga-Romany I, Alexander B, et al. PATH-08. THE IVY GLIOBLASTOMA PATIENT ATLAS - A NOVEL CLINICAL AND RADIO-GENOMICS RESOURCE FOR EARLY PHASE CLINICAL TRIAL DESIGN AND INTERPRETATION Neuro-Oncology. 20: vi159-vi159. DOI: 10.1093/Neuonc/Noy148.664  0.494
2017 Chung LK, Pelargos PE, Chan AM, Demos JV, Lagman C, Sheppard JP, Nguyen T, Chang YL, Hojat SA, Prins RM, Liau LM, Nghiemphu L, Lai A, Cloughesy TF, Yong WH, et al. Tissue microarray analysis for epithelial membrane protein-2 as a novel biomarker for gliomas. Brain Tumor Pathology. PMID 28887715 DOI: 10.1007/S10014-017-0300-1  0.327
2017 Dehghan Harati M, Yu A, Magaki SD, Perez-Rosendahl M, Im K, Park YK, Bergsneider M, Yong WH. Clinicopathologic features and pathogenesis of melanocytic colonization in atypical meningioma. Neuropathology : Official Journal of the Japanese Society of Neuropathology. PMID 28833600 DOI: 10.1111/Neup.12409  0.337
2017 Xu L, Chen Y, Dutra-Clarke M, Mayakonda A, Hazawa M, Savinoff SE, Doan N, Said JW, Yong WH, Watkins A, Yang H, Ding LW, Jiang YY, Tyner JW, Ching J, et al. BCL6 promotes glioma and serves as a therapeutic target. Proceedings of the National Academy of Sciences of the United States of America. PMID 28356518 DOI: 10.1073/Pnas.1609758114  0.314
2017 Hoffman HA, Li CH, Everson RG, Strunck JL, Yong WH, Lu DC. Primary lung metastasis of glioblastoma multiforme with epidural spinal metastasis: Case report. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 28343918 DOI: 10.1016/J.Jocn.2017.03.033  0.316
2017 Antonios JP, Soto H, Everson RG, Moughon D, Orpilla JR, Shin NP, Sedighim S, Treger J, Odesa S, Tucker A, Yong WH, Li G, Cloughesy TF, Liau LM, Prins RM. Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma. Neuro-Oncology. PMID 28115578 DOI: 10.1093/Neuonc/Now287  0.326
2017 Chen Y, Xu L, Dutra-Clarke M, Mayakonda A, Lin D, Koh L, Chong YK, Sandanaraj E, Madan V, Yang H, Doan N, Said JW, Yong WH, Müschen M, Ang BT, et al. Abstract 1524: BCL6 modulates the TP53 and STAT pathways in glioma Cancer Research. 77: 1524-1524. DOI: 10.1158/1538-7445.Am2017-1524  0.361
2016 Lee SJ, Bui TT, Chen CH, Lagman C, Chung LK, Sidhu S, Seo DJ, Yong WH, Siegal TL, Kim M, Yang I. Central Neurocytoma: A Review of Clinical Management and Histopathologic Features. Brain Tumor Research and Treatment. 4: 49-57. PMID 27867912 DOI: 10.14791/Btrt.2016.4.2.49  0.393
2016 Nguyen HN, Lie A, Li T, Chowdhury R, Liu F, Ozer B, Wei B, Green RM, Ellingson BM, Wang HJ, Elashoff R, Liau LM, Yong WH, Nghiemphu PL, Cloughesy T, et al. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy. Neuro-Oncology. PMID 27571882 DOI: 10.1093/Neuonc/Now189  0.302
2016 Ellingson BM, Nguyen HN, Lai A, Nechifor RE, Zaw O, Pope WB, Yong WH, Nghiemphu PL, Liau LM, Cloughesy TF. Contrast-enhancing tumor growth dynamics of preoperative, treatment-naive human glioblastoma. Cancer. PMID 26998740 DOI: 10.1002/Cncr.29957  0.327
2016 Magaki S, Gardner T, Khanlou N, Yong WH, Salamon N, Vinters HV. Brain biopsy in atypical dementia and primary angiitis of the CNS-reply. Human Pathology. PMID 26980043 DOI: 10.1016/J.Humpath.2015.08.027  0.306
2016 Hsu M, Sedighim S, Wang T, Antonios JP, Everson RG, Tucker AM, Du L, Emerson R, Yusko E, Sanders C, Robins H, Yong WH, Davidson TB, Li G, Liau LM, et al. TCR sequencing can identify and track glioma-infiltrating T cells after DC vaccination. Cancer Immunology Research. PMID 26968205 DOI: 10.1158/2326-6066.Cir-15-0240  0.36
2016 Choy W, Terterov S, Ung N, Kaprealian T, Trang A, DeSalles A, Chung LK, Martin N, Selch M, Bergsneider M, Yong W, Yang I. Adjuvant Stereotactic Radiosurgery and Radiation Therapy for the Treatment of Intracranial Chordomas. Journal of Neurological Surgery. Part B, Skull Base. 77: 38-46. PMID 26949587 DOI: 10.1055/S-0035-1554907  0.355
2016 Nguyen HN, Li T, Lie A, Ozer BH, Chowdhury R, Liu F, Wei B, Wang H, Elashoff RM, Liau LM, Yong WH, Ellingson BM, Nghiemphu PL, Cloughesy TF, Lai A. Benefit of MGMT methylation in glioblastoma in relation to hTERT promoter mutation. Journal of Clinical Oncology. 34: 2006-2006. DOI: 10.1200/Jco.2016.34.15_Suppl.2006  0.318
2016 Sedighim S, Hsu M, Wang T, Everson RG, Tucker A, Antonios JP, Du L, Emerson R, Yusko E, Sanders C, Robins H, Yong W, Davidson TB, Li G, Liau LM, et al. Abstract 767: TCR sequencing can identify and track tumor-specific T cell populations and is a predictive biomarker of response to DC vaccination in glioblastoma patients Cancer Research. 76: 767-767. DOI: 10.1158/1538-7445.Am2016-767  0.363
2016 Antonios J, Soto H, Everson R, Orpilla J, Shin N, Moughon D, Sedighim S, Treger J, Odesa S, Tucker A, Yong W, Cloughesy T, Prins R, Liau L. TMIC-16. TUMOR-INFILTRATING MYELOID CELLS MEDIATE ADAPTIVE IMMUNE RESISTANCE IN GLIOBLASTOMA Neuro-Oncology. 18: vi203-vi203. DOI: 10.1093/Neuonc/Now212.856  0.311
2015 Tso JL, Yang S, Menjivar JC, Yamada K, Zhang Y, Hong I, Bui Y, Stream A, McBride WH, Liau LM, Nelson SF, Cloughesy TF, Yong WH, Lai A, Tso CL. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide. Molecular Cancer. 14: 189. PMID 26546412 DOI: 10.1186/S12943-015-0459-1  0.319
2015 Yong WH, Shabihkhani M, Telesca D, Yang S, Tso JL, Menjivar JC, Wei B, Lucey GM, Mareninov S, Chen Z, Liau LM, Lai A, Nelson SF, Cloughesy TF, Tso CL. Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients. Plos One. 10: e0141334. PMID 26506620 DOI: 10.1371/Journal.Pone.0141334  0.379
2015 Everson RG, Antonios JP, Lisiero DN, Soto H, Scharnweber R, Garrett MC, Yong WH, Li N, Li G, Kruse CA, Liau LM, Prins RM. Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma. Neuro-Oncology. PMID 26330563 DOI: 10.1093/Neuonc/Nov153  0.343
2015 Choy W, Terterov S, Kaprealian TB, Trang A, Ung N, DeSalles A, Chung LK, Martin N, Selch M, Bergsneider M, Vinters HV, Yong WH, Yang I. Predictors of recurrence following resection of intracranial chordomas. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 26209919 DOI: 10.1016/J.Jocn.2015.05.024  0.367
2015 Pelargos P, Qin Y, Voth B, Thill K, Chung L, Prins R, Liau L, Ung N, Hojat S, Yong W, Gordon L, Wadehra M, Yang I. MPTH-27A LARGE-SCALE UCLA GLIOMA TISSUE MICROARRAY IDENTIFIES EMP2 AS A NOVEL BIOMARKER FOR GBM THAT CORRELATES WITH OVERALL PROGNOSIS Neuro-Oncology. 17: v144.2-v144. DOI: 10.1093/Neuonc/Nov222.27  0.365
2015 Liu F, Chowdhury R, Li T, Li S, Nguyen H, Wei B, Chou AP, Reiss JK, Mody RR, Liau LM, Nghiemphu PL, Yong WH, Cloughesy T, Lai A. EPIG-11THE IMPLICATION OF CpG island AND SPINT2 HYPERMETHYLATION IN BOTH IDH1 WILD-TYPE AND MUTANT ADULT DIFFUSE GLIOMAS Neuro-Oncology. 17: v88.3-v88. DOI: 10.1093/Neuonc/Nov214.11  0.341
2015 Pelargos P, Qin Y, Voth B, Thill K, Chung L, Prins R, Liau L, Ung N, Hojat S, Yong W, Gordon L, Wadehra M, Yang I. ATPS-62TARGETING OF NOVEL GBM BIOMARKER EMP2 RESULTS IN DECREASED TUMOR GROWTH AND INCREASED TUMOR NECROSIS Neuro-Oncology. 17: v31.5-v32. DOI: 10.1093/Neuonc/Nov204.62  0.37
2014 Li S, Chowdhury R, Liu F, Chou AP, Li T, Mody RR, Lou JJ, Chen W, Reiss J, Soto H, Prins R, Liau LM, Mischel PS, Nghiemphu PL, Yong WH, et al. Tumor-suppressive miR148a is silenced by CpG island hypermethylation in IDH1-mutant gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5808-22. PMID 25224277 DOI: 10.1158/1078-0432.Ccr-14-0234  0.339
2014 Bergsneider M, Mirsadraei L, Yong WH, Salamon N, Linetsky M, Wang MB, McArthur DL, Heaney AP. The pituitary stalk effect: is it a passing phenomenon? Journal of Neuro-Oncology. 117: 477-84. PMID 24549751 DOI: 10.1007/S11060-014-1386-5  0.304
2014 Avliyakulov NK, Rajavel KS, Le KM, Guo L, Mirsadraei L, Yong WH, Liau LM, Li S, Lai A, Nghiemphu PL, Cloughesy TF, Linetsky M, Haykinson MJ, Pope WB. C-terminally truncated form of αB-crystallin is associated with IDH1 R132H mutation in anaplastic astrocytoma. Journal of Neuro-Oncology. 117: 53-65. PMID 24473683 DOI: 10.1007/S11060-014-1371-Z  0.326
2014 Abad C, Nobuta H, Li J, Kasai A, Yong WH, Waschek JA. Targeted STAT3 disruption in myeloid cells alters immunosuppressor cell abundance in a murine model of spontaneous medulloblastoma. Journal of Leukocyte Biology. 95: 357-67. PMID 24068730 DOI: 10.1189/Jlb.1012531  0.366
2014 Hardy A, Prins R, Kong X, Woodworth D, Pope W, Yong W, Cloughesy T, Liau L, Ellingson B. NI-32 * ENHANCING TUMOR RESPONSE USING QUANTITATIVE VOLUMETRY FROM T1 SUBTRACTION MAPS IN MALIGNANT GLIOMA TREATED WITH DENDRITIC CELL VACCINATION Neuro-Oncology. 16: v145-v145. DOI: 10.1093/Neuonc/Nou264.30  0.347
2013 Ye F, Zhang Y, Liu Y, Yamada K, Tso JL, Menjivar JC, Tian JY, Yong WH, Schaue D, Mischel PS, Cloughesy TF, Nelson SF, Liau LM, McBride W, Tso CL. Protective properties of radio-chemoresistant glioblastoma stem cell clones are associated with metabolic adaptation to reduced glucose dependence. Plos One. 8: e80397. PMID 24260384 DOI: 10.1371/Journal.Pone.0080397  0.308
2013 Babic I, Anderson ES, Tanaka K, Guo D, Masui K, Li B, Zhu S, Gu Y, Villa GR, Akhavan D, Nathanson D, Gini B, Mareninov S, Li R, Camacho CE, ... ... Yong WH, et al. EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer. Cell Metabolism. 17: 1000-8. PMID 23707073 DOI: 10.1016/J.Cmet.2013.04.013  0.359
2013 Du L, Bergsneider M, Mirsadraei L, Young SH, Jonker JW, Downes M, Yong WH, Evans RM, Heaney AP. Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease. Proceedings of the National Academy of Sciences of the United States of America. 110: 8555-60. PMID 23653479 DOI: 10.1073/Pnas.1306182110  0.363
2013 Akhavan D, Pourzia AL, Nourian AA, Williams KJ, Nathanson D, Babic I, Villa GR, Tanaka K, Nael A, Yang H, Dang J, Vinters HV, Yong WH, Flagg M, Tamanoi F, et al. De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients. Cancer Discovery. 3: 534-47. PMID 23533263 DOI: 10.1158/2159-8290.Cd-12-0502  0.331
2013 Phillips JJ, Aranda D, Ellison DW, Judkins AR, Croul SE, Brat DJ, Ligon KL, Horbinski C, Venneti S, Zadeh G, Santi M, Zhou S, Appin CL, Sioletic S, Sullivan LM, ... ... Yong WH, et al. PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma. Brain Pathology (Zurich, Switzerland). 23: 565-73. PMID 23438035 DOI: 10.1111/Bpa.12043  0.333
2013 Prins RM, Wang X, Soto H, Young E, Lisiero DN, Fong B, Everson R, Yong WH, Lai A, Li G, Cloughesy TF, Liau LM. Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients. Journal of Immunotherapy (Hagerstown, Md. : 1997). 36: 152-7. PMID 23377664 DOI: 10.1097/Cji.0B013E3182811Ae4  0.31
2013 Ellingson BM, Lai A, Harris RJ, Selfridge JM, Yong WH, Das K, Pope WB, Nghiemphu PL, Vinters HV, Liau LM, Mischel PS, Cloughesy TF. Probabilistic radiographic atlas of glioblastoma phenotypes. Ajnr. American Journal of Neuroradiology. 34: 533-40. PMID 22997168 DOI: 10.3174/Ajnr.A3253  0.402
2013 zhang y, Liu Y, Menjivar JC, Tso J, Tian J, Yong WH, Liau LM, McBride W, Tso C. Abstract 3727: Overcoming of radiochemoresistance in glioblastoma stem cells via inhibition of lipid catabolism and SIRT1 deacetylase. Cancer Research. 73: 3727-3727. DOI: 10.1158/1538-7445.Am2013-3727  0.337
2013 Choy W, Nagasawa D, Trang A, Spasic M, Ooi Y, Terterov S, Yong W, Liau L, Martin N, DeSalles A, Kaprealian T, Selch M, Berg M. Prognostic Factors for Tumor Control Following Surgical Resection and Adjuvant Radiotherapy for Intracranial Chordomas Journal of Neurological Surgery Part B: Skull Base. 74. DOI: 10.1055/S-0033-1336176  0.336
2012 Lazovic J, Soto H, Piccioni D, Lou JR, Li S, Mirsadraei L, Yong W, Prins R, Liau LM, Ellingson BM, Cloughesy TF, Lai A, Pope WB. Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation. Neuro-Oncology. 14: 1465-72. PMID 23090985 DOI: 10.1093/Neuonc/Nos258  0.328
2012 Chou AP, Chowdhury R, Li S, Chen W, Kim AJ, Piccioni DE, Selfridge JM, Mody RR, Chang S, Lalezari S, Lin J, Sanchez DE, Wilson RW, Garrett MC, Harry B, ... ... Yong WH, et al. Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas. Journal of the National Cancer Institute. 104: 1458-69. PMID 22945948 DOI: 10.1093/Jnci/Djs357  0.381
2012 Carrillo JA, Lai A, Nghiemphu PL, Kim HJ, Phillips HS, Kharbanda S, Moftakhar P, Lalaezari S, Yong W, Ellingson BM, Cloughesy TF, Pope WB. Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma. Ajnr. American Journal of Neuroradiology. 33: 1349-55. PMID 22322613 DOI: 10.3174/Ajnr.A2950  0.343
2012 Pope WB, Mirsadraei L, Lai A, Eskin A, Qiao J, Kim HJ, Ellingson B, Nghiemphu PL, Kharbanda S, Soriano RH, Nelson SF, Yong W, Phillips HS, Cloughesy TF. Differential gene expression in glioblastoma defined by ADC histogram analysis: relationship to extracellular matrix molecules and survival. Ajnr. American Journal of Neuroradiology. 33: 1059-64. PMID 22268080 DOI: 10.3174/Ajnr.A2917  0.365
2012 Pope WB, Prins RM, Albert Thomas M, Nagarajan R, Yen KE, Bittinger MA, Salamon N, Chou AP, Yong WH, Soto H, Wilson N, Driggers E, Jang HG, Su SM, Schenkein DP, et al. Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy. Journal of Neuro-Oncology. 107: 197-205. PMID 22015945 DOI: 10.1007/S11060-011-0737-8  0.359
2012 Pertschuk D, Cloughesy TF, Chang SM, Aghi MK, Vogelbaum MA, Liau LM, Shafa BB, Yong WH, Chen C, Kesari S, Ibanez CE, Perez OD, Robbins JM, Jolly DJ, Gruber HE. Ascending dose trials of the safety and tolerability of Toca 511, a retroviral replicating vector encoding cytosine deaminase, in patients with recurrent high-grade glioma. Journal of Clinical Oncology. 30: 2101-2101. DOI: 10.1200/Jco.2012.30.15_Suppl.2101  0.343
2012 Babic I, Gini B, Tanaka K, Jacobs C, Yong WH, Cloughesy TF, Mischel PS. Abstract 4321: EGFR signaling in glioblastoma regulates the expression of a brain specific isoform ofalphaPIX/Arhgef6to promote invasion Cancer Research. 72: 4321-4321. DOI: 10.1158/1538-7445.Am2012-4321  0.321
2012 Bergsneider M, Wang MB, Suh J, Heaney A, Pham T, Yong W. High Incidence of Dural Tumor Infiltration in Endocrine Active Pituitary Tumors without MRI Evidence of Cavernous Sinus Invasion Skull Base Surgery. 73. DOI: 10.1055/S-0032-1312118  0.351
2011 Tanaka K, Babic I, Nathanson D, Akhavan D, Guo D, Gini B, Dang J, Zhu S, Yang H, De Jesus J, Amzajerdi AN, Zhang Y, Dibble CC, Dan H, Rinkenbaugh A, ... Yong WH, et al. Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance. Cancer Discovery. 1: 524-38. PMID 22145100 DOI: 10.1158/2159-8290.Cd-11-0124  0.309
2011 Lai A, Kharbanda S, Pope WB, Tran A, Solis OE, Peale F, Forrest WF, Pujara K, Carrillo JA, Pandita A, Ellingson BM, Bowers CW, Soriano RH, Schmidt NO, Mohan S, ... Yong WH, et al. Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4482-90. PMID 22025148 DOI: 10.1200/Jco.2010.33.8715  0.35
2011 Liu Y, Ye F, Yamada K, Tso JL, Zhang Y, Nguyen DH, Dong Q, Soto H, Choe J, Dembo A, Wheeler H, Eskin A, Schmid I, Yong WH, Mischel PS, et al. Autocrine endothelin-3/endothelin receptor B signaling maintains cellular and molecular properties of glioblastoma stem cells. Molecular Cancer Research : McR. 9: 1668-85. PMID 22013079 DOI: 10.1158/1541-7786.Mcr-10-0563  0.341
2011 Jijiwa M, Demir H, Gupta S, Leung C, Joshi K, Orozco N, Huang T, Yildiz VO, Shibahara I, de Jesus JA, Yong WH, Mischel PS, Fernandez S, Kornblum HI, Nakano I. CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway. Plos One. 6: e24217. PMID 21915300 DOI: 10.1371/Journal.Pone.0024217  0.338
2011 Ellison DW, Dalton J, Kocak M, Nicholson SL, Fraga C, Neale G, Kenney AM, Brat DJ, Perry A, Yong WH, Taylor RE, Bailey S, Clifford SC, Gilbertson RJ. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathologica. 121: 381-96. PMID 21267586 DOI: 10.1007/S00401-011-0800-8  0.38
2011 Lai A, Tran A, Nghiemphu PL, Pope WB, Solis OE, Selch M, Filka E, Yong WH, Mischel PS, Liau LM, Phuphanich S, Black K, Peak S, Green RM, Spier CE, et al. Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 142-8. PMID 21135282 DOI: 10.1200/Jco.2010.30.2729  0.331
2011 Prins RM, Soto H, Konkankit V, Odesa SK, Eskin A, Yong WH, Nelson SF, Liau LM. Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1603-15. PMID 21135147 DOI: 10.1158/1078-0432.Ccr-10-2563  0.37
2011 Solis OE, Mehta RI, Lai A, Mehta RI, Farchoukh LO, Green RM, Cheng JC, Natarajan S, Vinters HV, Cloughesy T, Yong WH. Rosette-forming glioneuronal tumor: a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 cases. Journal of Neuro-Oncology. 102: 477-84. PMID 20872044 DOI: 10.1007/S11060-010-0335-1  0.348
2010 Sun J, Masterman-Smith MD, Graham NA, Jiao J, Mottahedeh J, Laks DR, Ohashi M, DeJesus J, Kamei K, Lee KB, Wang H, Yu ZT, Lu YT, Hou S, Li K, ... ... Yong WH, et al. A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimens. Cancer Research. 70: 6128-38. PMID 20631065 DOI: 10.1158/0008-5472.Can-10-0076  0.358
2010 Panosyan EH, Laks DR, Masterman-Smith M, Mottahedeh J, Yong WH, Cloughesy TF, Lazareff JA, Mischel PS, Moore TB, Kornblum HI. Clinical outcome in pediatric glial and embryonal brain tumors correlates with in vitro multi-passageable neurosphere formation. Pediatric Blood & Cancer. 55: 644-51. PMID 20589659 DOI: 10.1002/Pbc.22627  0.387
2010 Butte PV, Fang Q, Jo JA, Yong WH, Pikul BK, Black KL, Marcu L. Intraoperative delineation of primary brain tumors using time-resolved fluorescence spectroscopy. Journal of Biomedical Optics. 15: 027008. PMID 20459282 DOI: 10.1117/1.3374049  0.319
2010 Prins RM, Soto H, Konkankit V, Yong WH, Nelson SF, Liau LM. Abstract 4749: Genetic signature of malignant glioma is associated with responsiveness to autologous tumor lysate-pulsed dendritic cell vaccination + TLR agonists Cancer Research. 70: 4749-4749. DOI: 10.1158/1538-7445.Am10-4749  0.308
2009 Guo D, Prins RM, Dang J, Kuga D, Iwanami A, Soto H, Lin KY, Huang TT, Akhavan D, Hock MB, Zhu S, Kofman AA, Bensinger SJ, Yong WH, Vinters HV, et al. EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Science Signaling. 2: ra82. PMID 20009104 DOI: 10.1126/Scisignal.2000446  0.356
2009 Laks DR, Masterman-Smith M, Visnyei K, Angenieux B, Orozco NM, Foran I, Yong WH, Vinters HV, Liau LM, Lazareff JA, Mischel PS, Cloughesy TF, Horvath S, Kornblum HI. Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells (Dayton, Ohio). 27: 980-7. PMID 19353526 DOI: 10.1002/Stem.15  0.373
2008 Prins RM, Odesa S, Soto H, Yong WH, Lai A, Bosch M, Boynton A, Cloughesy TF, Liau LM. Autologous tumor-lysate pulsed dendritic cell vaccination, together with the TLR-7 agonist 5% imiquimod, and serum pro- inflammatory cytokine levels in glioblastoma patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 11021. PMID 27947675 DOI: 10.1200/Jco.2008.26.15_Suppl.11021  0.348
2008 Brown PD, Krishnan S, Sarkaria JN, Wu W, Jaeckle KA, Uhm JH, Geoffroy FJ, Arusell R, Kitange G, Jenkins RB, Kugler JW, Morton RF, Rowland KM, Mischel P, Yong WH, et al. Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 5603-9. PMID 18955445 DOI: 10.1200/Jco.2008.18.0612  0.303
2008 Lasky JL, Choi EJ, Johnston S, Yong WH, Lazareff J, Moore T. Congenital brain tumors: case series and review of the literature. Journal of Pediatric Hematology/Oncology. 30: 326-31. PMID 18391706 DOI: 10.1097/Mph.0B013E3181647Bf0  0.389
2008 Lelievre V, Seksenyan A, Nobuta H, Yong WH, Chhith S, Niewiadomski P, Cohen JR, Dong H, Flores A, Liau LM, Kornblum HI, Scott MP, Waschek JA. Disruption of the PACAP gene promotes medulloblastoma in ptc1 mutant mice. Developmental Biology. 313: 359-70. PMID 18036580 DOI: 10.1016/J.Ydbio.2007.10.031  0.36
2006 Scoles DR, Yong WH, Qin Y, Wawrowsky K, Pulst SM. Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c). Human Molecular Genetics. 15: 1059-70. PMID 16497727 DOI: 10.1093/Hmg/Ddl021  0.345
2004 Yu JS, Liu G, Ying H, Yong WH, Black KL, Wheeler CJ. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Research. 64: 4973-9. PMID 15256471 DOI: 10.1158/0008-5472.Can-03-3505  0.35
2000 Yu JS, Wheeler CJ, Zeltzer PM, Nacis-Finger D, Lee PK, Prins R, Yong W, Thompson RC, Riedinger M, Zhang W, Black KL. 721 Vaccination of Recurrent Malignant Glioma Patients with Tumor-lysate Pulsed Dendritic Cells Elicits a Potent T-cell Anti-tumor Response Neurosurgery. 47: 505-505. DOI: 10.1097/00006123-200008000-00069  0.353
1995 Yong WH, Ueki K, Chou D, Reeves SA, von Deimling A, Gusella JF, Mohrenweiser HW, Buckler AJ, Louis DN. Cloning of a highly conserved human protein serine-threonine phosphatase gene from the glioma candidate region on chromosome 19q13.3. Genomics. 29: 533-6. PMID 8666404 DOI: 10.1006/Geno.1995.9972  0.599
1995 Yong WH, Southern JF, Pins MR, Warshaw AL, Compton CC, Lewandrowski KB. Cyst fluid NB/70K concentration and leukocyte esterase: two new markers for differentiating pancreatic serous tumors from pseudocysts. Pancreas. 10: 342-6. PMID 7792290 DOI: 10.1097/00006676-199505000-00004  0.316
1995 Yong WH, Chou D, Ueki K, Harsh GR, von Deimling A, Gusella JF, Mohrenweiser HW, Louis DN. Chromosome 19q deletions in human gliomas overlap telomeric to D19S219 and may target a 425 kb region centromeric to D19S112. Journal of Neuropathology and Experimental Neurology. 54: 622-6. PMID 7666049 DOI: 10.1097/00005072-199509000-00002  0.593
1995 Yong WH, Raffel C, von Deimling A, Louis DN. The APC gene in Turcot's syndrome. The New England Journal of Medicine. 333: 524. PMID 7662026 DOI: 10.1056/Nejm199508243330817  0.427
1995 Yong WH, Chou D, Ueki K, von Deimling A, Louis DN. THE CHROMOSOME 19q GLIOMA TUMOR SUPPRESSOR GENE Journal of Neuropathology and Experimental Neurology. 54: 439. DOI: 10.1097/00005072-199505000-00130  0.499
Show low-probability matches.